2m 2m 2m 2m 2m 2m 2m
C4 THERAPEUTICS (CCCC)
NASDAQ
$2.99-$0.15 (-4.81%)
Price as of Oct 02, 2026 5:34 PM EDT- $386.3MMarket Cap
- 42.08%1-Year Change
- BiotechnologyIndustry
C4 THERAPEUTICS (CCCC)
$2.99-$0.15 (-4.81%)
CCCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.14 | ||
Change | -$0.19 (-5.71%) | ||
Open | $3.31 | ||
High | $3.37 | ||
Low | $3.13 | ||
Previous Close | $3.33 | ||
Volume | 1,892,051 | ||
30-Day Average Volume | 2,061,949 | ||
1-Week Change | 3.63% | ||
1-Month Change | -18.86% | ||
1-Year Change | 42.08% | ||
3-Year Change | 68.82% | ||
5-Year Change | -93.17% | ||
Fundamentals | |||
Shares Outstanding | 123.0M | ||
Total Assets | $359.4M | ||
Market Cap | $386.3M | ||
Enterprise Value | $307.7M | ||
Period: QTR TTM FY | |||
Revenue | $6.6M | ||
Net Income | -$23.6M | ||
Free Cash Flow | -$1.6M | ||
EBIT | -$23.6M | ||
EBITDA | -$23.3M | ||
Net Working Capital | $214.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | -2 | ||
Price/Free Cash Flow | -240 | ||
Price/Operating Cash Flow | -245 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue